JP2016523925A5 - - Google Patents

Download PDF

Info

Publication number
JP2016523925A5
JP2016523925A5 JP2016524326A JP2016524326A JP2016523925A5 JP 2016523925 A5 JP2016523925 A5 JP 2016523925A5 JP 2016524326 A JP2016524326 A JP 2016524326A JP 2016524326 A JP2016524326 A JP 2016524326A JP 2016523925 A5 JP2016523925 A5 JP 2016523925A5
Authority
JP
Japan
Prior art keywords
amino
carbonyl
methylsulfamate
pyrimidin
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016524326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523925A (ja
JP6378759B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/045129 external-priority patent/WO2015002994A2/en
Publication of JP2016523925A publication Critical patent/JP2016523925A/ja
Publication of JP2016523925A5 publication Critical patent/JP2016523925A5/ja
Application granted granted Critical
Publication of JP6378759B2 publication Critical patent/JP6378759B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016524326A 2013-07-02 2014-07-01 Sumo活性化酵素阻害剤として有用なヘテロアリール化合物 Expired - Fee Related JP6378759B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842097P 2013-07-02 2013-07-02
US61/842,097 2013-07-02
PCT/US2014/045129 WO2015002994A2 (en) 2013-07-02 2014-07-01 Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Publications (3)

Publication Number Publication Date
JP2016523925A JP2016523925A (ja) 2016-08-12
JP2016523925A5 true JP2016523925A5 (cg-RX-API-DMAC7.html) 2017-08-10
JP6378759B2 JP6378759B2 (ja) 2018-08-22

Family

ID=52144279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016524326A Expired - Fee Related JP6378759B2 (ja) 2013-07-02 2014-07-01 Sumo活性化酵素阻害剤として有用なヘテロアリール化合物

Country Status (8)

Country Link
US (1) US9695154B2 (cg-RX-API-DMAC7.html)
EP (1) EP3016934B1 (cg-RX-API-DMAC7.html)
JP (1) JP6378759B2 (cg-RX-API-DMAC7.html)
CN (1) CN105492429A (cg-RX-API-DMAC7.html)
BR (1) BR112015032902A8 (cg-RX-API-DMAC7.html)
CA (1) CA2916468C (cg-RX-API-DMAC7.html)
EA (1) EA032577B1 (cg-RX-API-DMAC7.html)
WO (1) WO2015002994A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
HK1201817A1 (en) 2012-02-17 2015-09-11 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
WO2014022744A1 (en) 2012-08-03 2014-02-06 Millennium Pharmaceuticals, Inc. INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF Uba6
BR112015032902A8 (pt) 2013-07-02 2019-12-24 Millennium Pharm Inc compostos de heteroarila, seus usos e composições farmacêuticas
HRP20191979T1 (hr) 2014-07-01 2020-02-07 Millennium Pharmaceuticals, Inc. Heteoarilni spojevi koji su korisni kao inhibitori sumo-aktivirajućeg enzima
WO2017183927A1 (ko) * 2016-04-20 2017-10-26 한국화학연구원 신규한 헤테로고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
CN105670066A (zh) * 2016-04-22 2016-06-15 宁波硫华聚合物有限公司 橡胶促进剂活性剂氧化镁母胶粒及其制备方法
CN107586315B (zh) * 2016-07-08 2020-03-31 成都海创药业有限公司 一种嵌合分子
WO2018018035A1 (en) * 2016-07-22 2018-01-25 Virginia Commonwealth University Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-hmf) and its derivatives
BR112021000169A2 (pt) 2018-07-09 2021-04-06 Millennium Pharmaceuticals, Inc. Ministração de inibidor de enzima ativadora de sumo e anticorpos anti-cd20
PL3829581T3 (pl) 2018-07-27 2024-07-01 Arcus Biosciences, Inc. Antagoniści pirydonu a2r
WO2020028525A1 (en) * 2018-07-31 2020-02-06 City Of Hope Sumo inhibitor compounds and uses thereof
BR112021016795A8 (pt) 2019-02-27 2022-08-16 Millennium Pharm Inc Administração de inibidor de enzima de ativação de sumo e inibidores de checkpoint
WO2022159980A1 (en) * 2021-01-25 2022-07-28 Athos Therapeutics, Inc. Pharmaceutical compounds and methods of making and using the same
WO2023073645A1 (en) 2021-10-29 2023-05-04 Takeda Pharmaceutical Company Limited Therapy comprising anti-cd19 antibody and sumo-activating enzyme inhibitor
EP4596557A1 (en) * 2022-09-30 2025-08-06 Wigen Biomedicine Technology (Shanghai) Co., Ltd. Compound as inhibitor for sumo activating enzyme
WO2024097736A1 (en) * 2022-11-02 2024-05-10 Arcus Biosciences, Inc. Processes for preparing azolopyrimidine compounds
WO2024099438A1 (zh) * 2022-11-11 2024-05-16 微境生物医药科技(上海)有限公司 作为sumo活化酶抑制剂的化合物
CN116640068A (zh) * 2023-05-26 2023-08-25 康化(上海)新药研发有限公司 一种(3-环丙基-2-炔-1-基)甘氨酸苄酯的合成方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194446A (en) 1989-06-12 1993-03-16 A. H. Robins Company, Incorporated Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
AU6500696A (en) 1995-07-28 1997-02-26 Cubist Pharmaceuticals, Inc. Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
CA2477795A1 (en) 2002-02-28 2003-09-12 Kandasamy Sakthivel Nucleoside 5'-monophosphate mimics and their prodrugs
WO2004009610A2 (en) 2002-07-24 2004-01-29 Ptc Therapeutics, Inc. Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
US7291603B2 (en) 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
ES2283868T3 (es) 2002-09-04 2007-11-01 Schering Corporation Compuestos pirazol(1,5-a) pirimidina como inhibidores de quinasa dependiente de ciclina.
CN1310918C (zh) 2002-09-04 2007-04-18 先灵公司 作为细胞周期蛋白依赖激酶抑制剂的吡唑并嘧啶
WO2004043955A1 (en) 2002-11-13 2004-05-27 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
WO2004087707A1 (en) 2003-03-31 2004-10-14 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
WO2005037845A1 (en) 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
WO2005051949A1 (ja) 2003-11-26 2005-06-09 Dainippon Sumitomo Pharma Co., Ltd. 新規縮合イミダゾール誘導体
JP2008503591A (ja) 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ, インコーポレイテッド ユビキチンリガーゼ阻害剤
EP1848718B1 (en) 2005-02-04 2012-08-01 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
TWI333953B (en) 2005-10-06 2010-12-01 Schering Corp Pyrazolopyrimidines as protein kinase inhibitors
MY171289A (en) 2006-02-02 2019-10-07 Millennium Pharm Inc Inhibitors of e1 activating enzymes
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
JP5274460B2 (ja) * 2006-08-08 2013-08-28 ミレニアム ファーマシューティカルズ, インコーポレイテッド E1活性化酵素のインヒビターとして有用なヘテロアリール化合物
CN101765585B (zh) 2007-06-12 2017-03-15 尔察祯有限公司 抗菌剂
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
JP5731976B2 (ja) 2008-08-20 2015-06-10 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 置換ピリジン誘導体および置換ピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
CA2734487A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
WO2010022126A1 (en) 2008-08-20 2010-02-25 Schering Corporation Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734489C (en) 2008-08-20 2016-11-08 Southern Research Institute Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8962580B2 (en) 2008-09-23 2015-02-24 Alnylam Pharmaceuticals, Inc. Chemical modifications of monomers and oligonucleotides with cycloaddition
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
NZ596470A (en) 2009-05-14 2014-04-30 Millennium Pharm Inc Hydrochloride salt of ((1s,2s,4r)-4-{ 4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl} -2-hydroxycyclopentyl)methyl sulfamate
CN108752280A (zh) 2009-08-17 2018-11-06 纪念斯隆-凯特琳癌症中心 热休克蛋白结合化合物、组合物以及其制备和使用方法
WO2011100131A2 (en) 2010-01-28 2011-08-18 Alnylam Pharmacuticals, Inc. Monomers and oligonucleotides comprising cycloaddition adduct(s)
WO2011103441A1 (en) 2010-02-18 2011-08-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2542081A4 (en) 2010-03-01 2013-07-31 Gtx Inc COMPOSITIONS FOR CANCER TREATMENT
ES2823350T3 (es) 2010-07-29 2021-05-06 Rigel Pharmaceuticals Inc Compuestos heterocíclicos que activan AMPK y métodos de uso de los mismos
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
EP2748168A4 (en) 2011-08-24 2015-04-22 Millennium Pharm Inc HEMMER OF NEDD8-ACTIVATING ENZYME
US20150030601A1 (en) * 2011-10-07 2015-01-29 Millennium Pharmaceuticals, Inc. E1 enzyme mutants and uses thereof
US9221809B2 (en) 2011-10-31 2015-12-29 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
HK1201817A1 (en) 2012-02-17 2015-09-11 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
WO2013151975A1 (en) 2012-04-02 2013-10-10 Northeastern University Compositions and methods for the inhibition of methyltransferases
BR112015032902A8 (pt) 2013-07-02 2019-12-24 Millennium Pharm Inc compostos de heteroarila, seus usos e composições farmacêuticas
WO2015048547A2 (en) 2013-09-26 2015-04-02 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
RS59140B1 (sr) 2013-10-21 2019-09-30 Merck Patent Gmbh Heteroarilna jedinjenja kao inhibitori btk i njihova upotreba
WO2015110999A1 (en) 2014-01-24 2015-07-30 Piramal Enterprises Limited Ezh2 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2016523925A5 (cg-RX-API-DMAC7.html)
JP2016523911A5 (cg-RX-API-DMAC7.html)
TWI327137B (cg-RX-API-DMAC7.html)
RU2015143517A (ru) Пиразолсодержащие соединения и их применения
JP6378759B2 (ja) Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
TWI377910B (en) Hydrazide compound and pesticidal use of the same
HRP20230244T1 (hr) Derivati 3-(1-oksoizoindolin-2-il)piperidin-2,6-diona i njihova upotreba
JP2017502049A5 (cg-RX-API-DMAC7.html)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2010533158A5 (cg-RX-API-DMAC7.html)
RU2018145045A (ru) Соединения бензолсульфонамида и их применение в качестве терапевтических средств
JP2018520170A5 (cg-RX-API-DMAC7.html)
JP2011503166A5 (cg-RX-API-DMAC7.html)
CA2351725A1 (en) Substituted pyrazoles as p38 kinase inhibitors
RU2014110172A (ru) Гетероциклическое производное и фармацевтическое средство
JP2015500332A5 (cg-RX-API-DMAC7.html)
JP2019516737A5 (cg-RX-API-DMAC7.html)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
JP2013533868A5 (cg-RX-API-DMAC7.html)
JP2018530591A5 (cg-RX-API-DMAC7.html)
CA2670605A1 (en) Substituted arylpyrazoles
JP2011513221A5 (cg-RX-API-DMAC7.html)
RU2019113764A (ru) Соединения хиноксалина в качестве ингибиторов рецепторной тирозинкиназы iii типа
JP2008526840A5 (cg-RX-API-DMAC7.html)